SBIR-STTR Award

StampPump: a Postage-Stamp Sized Autonomous Glycemic Control Mechanism for Patients Suffering Glycemic Abnormalities as a Result of Critical Illnesses
Award last edited on: 3/17/21

Sponsored Program
STTR
Awarding Agency
DOD : DARPA
Total Award Amount
$224,124
Award Phase
1
Solicitation Topic Code
ST18C-004
Principal Investigator
Michael Dodson Michael

Company Information

Thermalin Inc

39 Karen Road
Waban, MA 02468
   (617) 938-3510
   info@thermalin.com
   www.thermalin.com

Research Institution

Indiana University School of Medicine

Phase I

Contract Number: W911NF19C0029
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2019
Phase I Amount
$224,124
StampPump is a postage-stamp-sized (27x27x6 mm), fully-self-contained, closed-loop insulin patch pump system that is filled at the factory with enough insulin to treat a person with T1- or trauma-induced hyperglycemia for a full week. The device is shelf stable for at least 90 days and so is compatible with critical-care or forward deployment use. We propose to augment this system with the ability to control delivery of counter-regulatory medications -- either glucagon or dextrose -- so that it can automatically mitigate hyperglycemia while reducing the risk of hypoglycemia. The augmented system would be designed for simple deployment by critical care nurses or even field medics

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----